Heterogeneity of HPA‐3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes

Ines Socher,Claudia Zwingel,S. Santoso,H. Kroll
DOI: https://doi.org/10.1111/j.1537-2995.2007.01550.x
2008-03-01
Transfusion
Abstract:BACKGROUND: Immunization against the human platelet alloantigen (HPA)‐3a residing on αIIbβ3 integrin accounts for approximately 2 percent of fetal and neonatal alloimmune thrombocytopenia (FNAIT). Anti‐HPA‐3a alloantibodies are sometimes difficult to detect and can be overlooked by standard antigen capture assays.
What problem does this paper attempt to address?